NRS 453.151
Cooperative arrangements

  • confidentiality of information.

1.

The Board and the Division shall cooperate with federal and other state agencies in discharging their responsibilities concerning traffic in controlled substances and in suppressing the abuse of controlled substances. To this end, the Board and Division may:

(a)

Arrange for the exchange of information among governmental officials concerning the use and abuse of controlled substances;

(b)

Coordinate and cooperate in training programs concerning controlled substance law enforcement at local and state levels;

(c)

Cooperate with the Drug Enforcement Administration by establishing a centralized unit to accept, catalog, file and collect statistics, including records of drug-dependent persons and other controlled substance law offenders within the State, and make the information available for federal, state and local law enforcement purposes. The Board and the Division shall not furnish the name or identity of a patient or research subject whose identity could not be obtained pursuant to NRS 453.157; and

(d)

Conduct programs of eradication aimed at destroying the wild growth or illicit propagation of plant species from which controlled substances may be extracted.

2.

Results, information and evidence received from the Drug Enforcement Administration relating to the regulatory functions of the provisions of NRS 453.011 to 453.552, inclusive, including results of inspections conducted by it, may be relied and acted upon by the Board in the exercise of its regulatory functions pursuant to NRS 453.011 to 453.552, inclusive.

Source: Section 453.151 — Cooperative arrangements; confidentiality of information., https://www.­leg.­state.­nv.­us/NRS/NRS-453.­html#NRS453Sec151.

453.011
Short title
453.013
Uniformity of interpretation.
453.016
Definitions.
453.021
“Administer” defined.
453.023
“Advanced practice registered nurse” defined.
453.026
“Agent” defined.
453.031
“Board” defined.
453.033
“CBD” defined.
453.038
“Chart order” defined.
453.039
“Compound” and “compounding” defined.
453.042
“Concentrated cannabis” defined.
453.043
“Controlled substance analog” defined.
453.046
“Counterfeit substance” defined.
453.051
“Deliver” and “delivery” defined.
453.053
“Department” defined.
453.056
“Dispense” defined.
453.061
“Dispenser” defined.
453.066
“Distribute” defined.
453.071
“Distributor” defined.
453.076
“Division” defined.
453.081
“Drug” defined.
453.082
“Drug Enforcement Administration” defined.
453.083
“Fill” defined.
453.085
“Hospital” defined.
453.086
“Immediate precursor” defined.
453.087
“Institutional pharmacy” defined.
453.091
“Manufacture” defined.
453.096
“Marijuana” defined.
453.098
“Narcotic addict” defined.
453.099
“Narcotic addiction” defined.
453.101
“Narcotic drug” defined.
453.103
“Narcotic use disorder” defined.
453.106
“Opiate” defined.
453.111
“Opium poppy” defined.
453.113
“Person” defined.
453.115
“Person with a narcotic use disorder” defined.
453.117
“Pharmacy” defined.
453.118
“Pharmacy in a correctional institution” defined.
453.121
“Poppy straw” defined.
453.126
“Practitioner” defined.
453.128
“Prescription” defined.
453.131
“Production” defined.
453.134
“Refill” defined.
453.136
“State” defined.
453.137
“Steroid” defined.
453.139
“THC” defined.
453.141
“Ultimate user” defined.
453.146
Powers and duties of Board.
453.151
Cooperative arrangements
453.153
Cooperation between Board and Division required.
453.154
Division required to prepare certain reports concerning controlled substances
453.155
Programs for research and education.
453.157
Confidentiality of information concerning research or medical practice.
453.159
Existing orders or regulations unaffected.
453.0825
“Extraction” defined.
453.0875
“Isomer” defined.
Last Updated

Feb. 5, 2021

§ 453.151’s source at nv​.us